| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |